Drugs commonly used to treat enlarged prostate symptoms may also protect against a common form of dementia, scientists believe. Researchers found men who took terazosin, doxazosin, and alfuzosin were ...

New drug hope for prostate cancer patients They also found an association between patients who had higher levels of these proteins and poorer overall survival. In one cohort they studied, patients ...

AUSTIN, Texas and TOKYO, Nov. 21, 2025 /PRNewswire/ -- According to DataM Intelligence, the Prostate Cancer Drugs Market Size reached USD 13.22 billion in 2024 and is projected to grow significantly ...

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects Thousands of men with advanced prostate cancer in England are to be ...

For the first time, patients whose prostate cancer has not spread will be eligible for the drug abiraterone in England, after NHS chiefs widened access to the treatment.

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth and slow symptom advance. File Photo by Billie Jean Shaw/UPI A new ...

“Drug resistance is one of the biggest problems we face in treating cancer. Finding drugs that can slow down cancer’s growth when all other treatments have stopped working is critical. “This research ...

AUSTIN, Texas and TOKYO, Nov. 21, 2025 /PRNewswire/ -- According to DataM Intelligence, the Prostate Cancer Drugs Market Size reached USD 13.22 billion in 2024 and is projected to grow significantly ...